Showing results (2601-2610 of 9,653) with videos related to
Sort By:
Pageof 966
Leukemia|April 1, 1993
Acute myeloid leukemias expressing lymphoid-associated antigens: diagnostic incidence and prognostic significanceH G Drexler, E Thiel, W D LudwigLeukemia|May 1, 1993
Pilot study of 5-aza-2'-deoxycytidine (Decitabine) in the treatment of poor prognosis acute myelogenous leukemia patients: preliminary resultsM C Petti, F Mandelli, V Zagonel, et al.Leukemia|May 1, 1993
Preliminary results with 5-aza-2'-deoxycytidine (DAC)-containing chemotherapy in patients with relapsed or refractory acute leukemia. The EORTC Leukemia Cooperative GroupR Willemze, E Archimbaud, P MuusLeukemia|April 7, 2021
Hematopoietic stem progenitor cells lacking HLA differ from those lacking GPI-anchored proteins in the hierarchical stage and sensitivity to immune attack in patients with acquired aplastic anemiaTakeshi Yoroidaka, Kohei Hosokawa, Tatsuya Imi, et al.Leukemia|April 7, 2021
Unmanipulated haploidentical hematopoietic stem cell transplantation is an excellent option for children and young adult relapsed/refractory Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia after CAR-T-cell therapyGuan-Hua Hu, Xiang-Yu Zhao, Ying-Xi Zuo, et al.Leukemia|April 7, 2021
RNA-sequencing data-driven dissection of human plasma cell differentiation reveals new potential transcription regulatorsAlboukadel Kassambara, Laurie Herviou, Sara Ovejero, et al.Leukemia|July 15, 2020
Which lower risk myelodysplastic syndromes should be treated with allogeneic hematopoietic stem cell transplantation?Marie Robin, Pierre FenauxLeukemia|July 16, 2020
Retraction Note: LAMP2 expression dictates azacytidine response and prognosis in MDS/AMLAlix Dubois, Nathan Furstoss, Anne Calleja, et al.Leukemia|July 21, 2020
Bortezomib-based induction, high-dose melphalan and lenalidomide maintenance in myeloma up to 70 years of ageElias K Mai, Kaya Miah, Uta Bertsch, et al.Pageof 966